Zentalis Announces Presentation of Positive Phase 1b Data
Strong anti-tumor activity shown in a platinum-resistant ovarian cancer population, with a confirmed ORR of 50.0% and mPFS of 7.4 months in combination...
Source: globenewswire.com
📰 Frequent Grade News
Frequent Grade News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Frequent Grade. Real-time updates on events, politics, business and more.